Healthcare costs and resource use in advanced breast cancer at the end of life: a register study
Open Access
- 6 February 2026
- journal article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 65, 75-82
Abstract
Background and purpose: Advanced breast cancer (ABC) involves substantial end-of-life (EOL) healthcare use and costs. Understanding cost drivers can inform care delivery and resource allocation.Patient/material and methods: We conducted a retrospective, population-based study of individuals (n = 1,437) who died with breast cancer in the Stockholm Region (2015–2023). Healthcare utilization and costs during the last 12 months of life were obtained from the Stockholm Regional Healthcare Data Repository (VAL) and estimated using the Region Stockholm cost model. Variables included age, sex, socioeconomic status (Mosaic), Charlson Comorbidity Index, Hospital Frailty Risk Score (HFRS), systemic therapy, and place of death. Descriptive statistics and generalized linear models assessed cost associations.Results: Total costs rose toward EOL, increasing 140% in the final 3 months versus the prior quarter. Hospitalizations and specialized palliative care drove costs, while outpatient visits declined. Younger age (18–69 years), high frailty (HFRS > 15), and systemic therapy were independently associated with higher costs. Hospital death was associated with lower expenditures than dying elsewhere (rate ratio [RR]: 0.84, 95% confidence interval [CI]: 0.78–0.91). The top 5% of cost users were mainly younger, frail patients receiving systemic therapy.Interpretation: ABC-related costs escalate in the final year of life, driven by hospitalizations, palliative care, and systemic therapies. Younger, frailer patients incur higher costs, while those dying in hospital settings are associated with lower costs. Early palliative integration and frailty-based risk stratification were associated with distinct patterns of healthcare utilization and costs toward the EOL.Keywords
This publication has 49 references indexed in Scilit:
- Why is end‐of‐life inpatient cost high among cancer patients? A prospective cohort studyCancer Medicine, 2024
- Equal receipt of specialized palliative care in breast and prostate cancer: a register studySupportive Care in Cancer, 2022
- Care of the adult cancer patient at the end of life: ESMO Clinical Practice GuidelinesESMO Open, 2021
- Medical costs associated with metastatic breast cancer in younger, midlife, and older womenBreast Cancer Research and Treatment, 2020
- The cost of cancer in Europe 2018European Journal of Cancer, 2020
- Addressing frailty in patients with breast cancer: A review of the literatureEuropean Journal of Surgical Oncology, 2020
- Impact of aggressive management and palliative care on cancer costs in the final month of lifeCancer, 2015
- Designing Health Care for the Most Common Chronic Condition—MultimorbidityJAMA, 2012
- The economic burden of metastatic breast cancer: A systematic review of literature from developed countriesCancer Treatment Reviews, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008